UBS Lux Equity Fund Biotech USD vs Atlant Stability

UBS Lux Equity Fund Biotech USD vs Atlant Stability

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. Atlant Stability

  • Security

    Atlant Stability

  • Fee

    0.50%

  • ISIN

    SE0002623553

  • Holdings

    20

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.35) and Moderna (9.21). In comparison with Atlant Stability, we have 1 holdings where is the largest holding (8.89), followed by (3.16) and (3.03).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Atlant Stability.

UBS Lux Equity Fund Biotech USD Atlant Stability
1. Regeneron Pharmaceuticals Inc
10.04 %
1.
8.89 %
2. Vertex Pharmaceuticals Inc
9.35 %
2.
3.16 %
3. Moderna Inc
9.21 %
3.
3.03 %
4. Alnylam Pharmaceuticals Inc
6.96 %
4.
2.86 %
5. AbbVie Inc
USA
5.53 %
5.
2.42 %
6. Gilead Sciences Inc
USA
4.66 %
6.
2.15 %
7. Amgen Inc
4.3 %
7.
2.08 %
8. BioNTech SE
4.13 %
8.
1.98 %
9. Karuna Therapeutics Inc
3.75 %
9.
1.87 %
10. Royalty Pharma Plc
3.37 %
10.
1.76 %
- 11.
1.65 %
- 12.
1.65 %
- 13.
1.54 %
- 14.
1.49 %
- 15.
1.47 %
- 16.
1.46 %
- 17.
1.44 %
- 18.
1.4 %
- 19.
1.35 %
- 20.
1.31 %

The list of fund holdings was last updated on June 5, 2025.